aTyr Pharma, Inc. Common Stock
Symbol: ATYR (NASDAQ)
5.27
▲ (0.57%) 0.030
Company Description:
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Key Stats
- Today's Open: $5.2
- Today's High: $5.567
- Today's Low: $5.185
- Today's Volume: 4.75M
- Yesterday Close: $5.24
- Yesterday High: $5.435
- Yesterday Low: $5.08
- Yesterday Volume: 4.08M
- Last Min Volume: 50
- Last Min High: $5.27
- Last Min Low: $5.27
- Last Min VWAP: $5.27
Company Profile
- Name: aTyr Pharma, Inc. Common Stock
- Website: https://www.atyrpharma.com
- Listed Date: 2015-05-07
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001339970
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $513.45M
- Round Lot: 100
- Outstanding Shares: 97.99M
- Asset Type: CS
RECENT FILINGS FOR ATYR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | EFFECT | View |
| 2025-08-08 | 8-K/A | View |
| 2025-08-07 | S-8 | View |
| 2025-08-07 | S-3 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-07 | 8-K | View |
| 2025-05-06 | 8-K | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-03-19 | ARS | View |
| 2025-03-19 | DEFA14A | View |
Latest News on ATYR